|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Acquisition related costs | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Other expense, net | |||||
| Loss before income taxes | |||||
| Income tax expense | |||||
| Net loss | |||||
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | |||||
| Net Income (Loss) Available to Common Stockholders, Diluted | |||||
| Net loss attributable to common stockholders and comprehensive loss | |||||
| Net loss per share attributable to common stockholders, basic (in dollars per share) | |||||
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | |||||
| Weighted-average shares used to compute basic net loss per share (in shares) | |||||
| Weighted-average shares used to compute diluted net loss per share (in shares) |
Loading...